Seyedinia, S.S.; Mirshahvalad, S.A.; Schweighofer-Zwink, G.; Hehenwarter, L.; Rendl, G.; Pirich, C.; Beheshti, M.
Evolving Role of [18F]Flurocholine PET/CT in Assessing Primary Hyperparathyroidism: Can It Be Considered the First-Line Functional Imaging Approach? J. Clin. Med. 2023, 12, 812.
https://doi.org/10.3390/jcm12030812
AMA Style
Seyedinia SS, Mirshahvalad SA, Schweighofer-Zwink G, Hehenwarter L, Rendl G, Pirich C, Beheshti M.
Evolving Role of [18F]Flurocholine PET/CT in Assessing Primary Hyperparathyroidism: Can It Be Considered the First-Line Functional Imaging Approach? Journal of Clinical Medicine. 2023; 12(3):812.
https://doi.org/10.3390/jcm12030812
Chicago/Turabian Style
Seyedinia, Seyedeh Sara, Seyed Ali Mirshahvalad, Gregor Schweighofer-Zwink, Lukas Hehenwarter, Gundula Rendl, Christian Pirich, and Mohsen Beheshti.
2023. "Evolving Role of [18F]Flurocholine PET/CT in Assessing Primary Hyperparathyroidism: Can It Be Considered the First-Line Functional Imaging Approach?" Journal of Clinical Medicine 12, no. 3: 812.
https://doi.org/10.3390/jcm12030812
APA Style
Seyedinia, S. S., Mirshahvalad, S. A., Schweighofer-Zwink, G., Hehenwarter, L., Rendl, G., Pirich, C., & Beheshti, M.
(2023). Evolving Role of [18F]Flurocholine PET/CT in Assessing Primary Hyperparathyroidism: Can It Be Considered the First-Line Functional Imaging Approach? Journal of Clinical Medicine, 12(3), 812.
https://doi.org/10.3390/jcm12030812